| REEBX | SCIIX | REEBX / SCIIX | |
| Total Expense Ratio | 1.27 | 1.30 | 98% |
| Annual Report Gross Expense Ratio | 1.27 | 1.41 | 90% |
| Fund Existence | 12 years | 30 years | - |
| Gain YTD | 11.372 | -1.526 | -745% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 137B | 241M | 56,846% |
| Annual Yield % from dividends | 2.23 | 0.29 | 755% |
| Returns for 1 year | 14.10 | -2.72 | -518% |
| Returns for 3 years | 30.10 | -20.26 | -149% |
| Returns for 5 years | -3.87 | -35.32 | 11% |
| Returns for 10 years | 55.67 | -24.06 | -231% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| URNJ | 29.93 | 1.68 | +5.95% |
| Sprott Junior Uranium Miners ETF | |||
| DCOR | 82.47 | 0.37 | +0.45% |
| Dimensional US Core Equity 1 ETF | |||
| MYCJ | 24.64 | N/A | N/A |
| State Street® My2030 Corporate Bond ETF | |||
| BBP | 83.56 | -0.91 | -1.08% |
| Virtus LifeSci Biotech Products ETF | |||
| TXXS | 3.18 | -0.44 | -12.11% |
| 21Shares 2x Long Sui ETF | |||